Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
6.28
-0.10 (-1.57%)
At close: May 12, 2025, 4:00 PM
6.98
+0.70 (11.15%)
After-hours: May 12, 2025, 7:25 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $41.33 million as of May 12, 2025. Its market cap has increased by 57.76% in one year.
Market Cap
41.33M
Enterprise Value
-17.03M
1-Year Change
57.76%
Ranking
Category
Stock Price
$6.28
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $41.33M, a decrease of -80.64%. That is a compound annual growth rate of -18.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 42.00M | 26.51% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |